Specifically, pathogenic variants in the N-terminal domain of MYO15A have been suggested to be associated with residual hearing [5–8], especially at low frequencies, while pathogenic variants in other domains resulted in congenital severe-to-profound hearing loss [1, 10–15]. Here, MYO15A is linked to hearing loss disorder.